BMP signaling in vascular diseases

FEBS Letters

Volumn 586, Issue 14, 2012, Pages 1993-2002

  Cai, Jie ^a   Pardali, Evangelia ^b   Sánchez Duffhues, Gonzalo ^a   Ten Dijke, Peter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

BMP signaling; Cardiovascular disease; Hereditary hemorrhagic telangiectasia; Pulmonary arterial hypertension; Tumor angiogenesis; Vascular calcification

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 9; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; ENDOGLIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; SMAD PROTEIN; TYROSINE PROTEIN PHOSPHATASE NON RECEPTOR TYPE 14 PROTEIN; UNCLASSIFIED DRUG;

ACTIVIN RECEPTOR LIKE KINASE 1 GENE; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CELL FUNCTION; DISEASE MARKER; ENDOTHELIUM CELL; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MUTATOR GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; REVIEW; SIGNAL TRANSDUCTION; SMAD8 GENE; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; HUMANS; HYPERTENSION, PULMONARY; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MODELS, GENETIC; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; SMAD PROTEINS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; VASCULAR CALCIFICATION; VASCULAR DISEASES;

MUS;

EID: 84862768629     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.04.030     Document Type: Review

References (175)

1. J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, and E.A. Wang Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534
2. M.R. Urist Bone: formation by autoinduction Science 150 1965 893 899
3. J. Massague, and Y.G. Chen Controlling TGF-β signaling Genes Dev. 14 2000 627 644
4. K. Miyazono, Y. Kamiya, and M. Morikawa Bone morphogenetic protein receptors and signal transduction J. Biochem. 147 2010 35 51
5. M. Kawabata, T. Imamura, and K. Miyazono Signal transduction by bone morphogenetic proteins Cytokine Growth Factor Rev. 9 1998 49 61
6. S.M. Nelsen, and J.L. Christian Site-specific cleavage of BMP-4 by furin, PC6, and PC7 J. Biol. Chem. 284 2009 27157 27166
7. B. Bragdon, O. Moseychuk, S. Saldanha, D. King, J. Julian, and A. Nohe Bone morphogenetic proteins: a critical review Cell Signal. 23 2011 609 620
8. J.P. Annes, J.S. Munger, and D.B. Rifkin Making sense of latent TGF-β activation J. Cell Sci. 116 2003 217 224
9. E. Canalis, A.N. Economides, and E. Gazzerro Bone morphogenetic proteins, their antagonists, and the skeleton Endocr. Rev. 24 2003 218 235
10. O. Avsian-Kretchmer, and A.J. Hsueh Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists Mol. Endocrinol. 18 2004 1 12
11. M. Moser, O. Binder, Y. Wu, J. Aitsebaomo, R. Ren, C. Bode, V.L. Bautch, F.L. Conlon, and C. Patterson BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation Mol. Cell Biol. 23 2003 5664 5679
12. A.F. Zebboudj, M. Imura, and K. Bostrom Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2 J. Biol. Chem. 277 2002 4388 4394
13. Z. Zhou, J. Xie, D. Lee, Y. Liu, J. Jung, L. Zhou, S. Xiong, L. Mei, and W.C. Xiong Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation Dev. Cell 19 2010 90 102
14. M. Hagihara, M. Endo, K. Hata, C. Higuchi, K. Takaoka, H. Yoshikawa, and T. Yamashita Neogenin, a receptor for bone morphogenetic proteins J. Biol. Chem. 286 2011 5157 5165
15. R. Wallin, D. Cain, S.M. Hutson, D.C. Sane, and R. Loeser Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2) Thromb. Haemost. 84 2000 1039 1044
16. Y. Yao, A. Shahbazian, and K.I. Bostrom Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4 Circ. Res. 102 2008 1065 1074
17. Y. Yao, S. Nowak, A. Yochelis, A. Garfinkel, and K.I. Bostrom Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development J. Biol. Chem. 282 2007 30131 30142
18. S.J. Cole, D. Bradford, and H.M. Cooper Neogenin: a multi-functional receptor regulating diverse developmental processes Int. J. Biochem. Cell Biol. 39 2007 1569 1575
19. M. De Vries, and H.M. Cooper Emerging roles for neogenin and its ligands in CNS development J. Neurochem. 106 2008 1483 1492
20. D.W. Walsh, C. Godson, D.P. Brazil, and F. Martin Extracellular BMP-antagonist regulation in development and disease: tied up in knots Trends Cell Biol. 20 2010 244 256
21. C.H. Heldin, K. Miyazono, and P. ten Dijke TGF-β signalling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471
22. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-β family signalling Nature 425 2003 577 584
23. B.L. Rosenzweig, T. Imamura, T. Okadome, G.N. Cox, H. Yamashita, P. ten Dijke, C.H. Heldin, and K. Miyazono Cloning and characterization of a human type II receptor for bone morphogenetic proteins Proc. Natl. Acad. Sci. U S A 92 1995 7632 7636
24. A. Moustakas, and C.H. Heldin The regulation of TGF-β signal transduction Development 136 2009 3699 3714
25. P. ten Dijke, M.J. Goumans, and E. Pardali Endoglin in angiogenesis and vascular diseases Angiogenesis 11 2008 79 89
26. K.C. Kirkbride, T.A. Townsend, M.W. Bruinsma, J.V. Barnett, and G.C. Blobe Bone morphogenetic proteins signal through the transforming growth factor-β type III receptor J. Biol. Chem. 283 2008 7628 7637
27. L. David, C. Mallet, S. Mazerbourg, J.J. Feige, and S. Bailly Identification of BMP-9 and BMP-10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells Blood 109 2007 1953 1961
28. D. Onichtchouk, Y.G. Chen, R. Dosch, V. Gawantka, H. Delius, J. Massague, and C. Niehrs Silencing of TGF-β signalling by the pseudoreceptor BAMBI Nature 401 1999 480 485
29. J.L. Babitt, Y. Zhang, T.A. Samad, Y. Xia, J. Tang, J.A. Campagna, A.L. Schneyer, C.J. Woolf, and H.Y. Lin Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor J. Biol. Chem. 280 2005 29820 29827
30. T.A. Samad, A. Rebbapragada, E. Bell, Y. Zhang, Y. Sidis, S.J. Jeong, J.A. Campagna, S. Perusini, D.A. Fabrizio, A.L. Schneyer, H.Y. Lin, A.H. Brivanlou, L. Attisano, and C.J. Woolf DRAGON, a bone morphogenetic protein co-receptor J. Biol. Chem. 280 2005 14122 14129
31. J.L. Babitt, F.W. Huang, D.M. Wrighting, Y. Xia, Y. Sidis, T.A. Samad, J.A. Campagna, R.T. Chung, A.L. Schneyer, C.J. Woolf, N.C. Andrews, and H.Y. Lin Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression Nat. Genet. 38 2006 531 539
32. B. Andriopoulos Jr., E. Corradini, Y. Xia, S.A. Faasse, S. Chen, L. Grgurevic, M.D. Knutson, A. Pietrangelo, S. Vukicevic, H.Y. Lin, and J.L. Babitt BMP-6 is a key endogenous regulator of hepcidin expression and iron metabolism Nat. Genet. 41 2009 482 487
33. E. Corradini, J.L. Babitt, and H.Y. Lin The RGM/DRAGON family of BMP co-receptors Cytokine Growth Factor Rev. 20 2009 389 398
34. S. Ross, and C.S. Hill How the Smads regulate transcription Int. J. Biochem. Cell Biol. 40 2008 383 408
35. H. Zhu, P. Kavsak, S. Abdollah, J.L. Wrana, and G.H. Thomsen A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation Nature 400 1999 687 693
36. A.A. Ogunjimi, D.J. Briant, N. Pece-Barbara, C. Le Roy, G.M. Di Guglielmo, P. Kavsak, R.K. Rasmussen, B.T. Seet, F. Sicheri, and J.L. Wrana Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain Mol. Cell 19 2005 297 308
37. G. Murakami, T. Watabe, K. Takaoka, K. Miyazono, and T. Imamura Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads Mol. Biol. Cell 14 2003 2809 2817
38. Y.E. Zhang Non-Smad pathways in TGF-β signaling Cell Res. 19 2009 128 139
39. J. Massague, and D. Wotton Transcriptional control by the TGF-β/Smad signaling system EMBO J. 19 2000 1745 1754
40. K.M. Mulder Role of Ras and Mapks in TGF-β signaling Cytokine Growth Factor Rev. 11 2000 23 35
41. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
42. M. Hellström, L.K. Phng, J.J. Hofmann, E. Wallgard, L. Coultas, P. Lindblom, J. Alva, A.K. Nilsson, L. Karlsson, N. Gaiano, K. Yoon, J. Rossant, M.L. Iruela-Arispe, M. Kalén, H. Gerhardt, and C. Betsholtz Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis Nature 445 2007 776 780
43. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, M. Jeltsch, C. Mitchell, K. Alitalo, D. Shima, and C. Betsholtz VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J. Cell Biol. 161 2003 1163 1177
44. C. Ruhrberg, H. Gerhardt, M. Golding, R. Watson, S. Ioannidou, H. Fujisawa, C. Betsholtz, and D.T. Shima Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis Genes Dev. 16 2002 2684 2698
45. E.M. Conway, D. Collen, and P. Carmeliet Molecular mechanisms of blood vessel growth Cardiovasc. Res. 49 2001 507 521
46. E. Pardali, D.W. van der Schaft, E. Wiercinska, A. Gorter, P.C. Hogendoorn, A.W. Griffioen, and P. ten Dijke Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma Oncogene 30 2011 334 345
47. M.J. Goumans, and C. Mummery Functional analysis of the TGF-β receptor/Smad pathway through gene ablation in mice Int. J. Dev. Biol. 44 2000 253 265
48. D. Lyden, A.Z. Young, D. Zagzag, W. Yan, W. Gerald, R. O'Reilly, B.L. Bader, R.O. Hynes, Y. Zhuang, K. Manova, and R. Benezra Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts Nature 401 1999 670 677
49. L. David, J.J. Feige, and S. Bailly Emerging role of bone morphogenetic proteins in angiogenesis Cytokine Growth Factor Rev. 20 2009 203 212
50. E. Pardali, and P. Ten Dijke TGF-β signaling and cardiovascular diseases Int. J. Biol. Sci. 8 2012 195 213
51. G. Valdimarsdottir, M.J. Goumans, A. Rosendahl, M. Brugman, S. Itoh, F. Lebrin, P. Sideras, and P. ten Dijke Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells Circulation 106 2002 2263 2270
52. M.M. Deckers, R.L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van Der Bent, S.E. Papapoulos, and C.W. Lowik Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A Endocrinology 143 2002 1545 1553
53. Y. Suzuki, N. Ohga, Y. Morishita, K. Hida, K. Miyazono, and T. Watabe BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo J. Cell Sci. 123 2010 1684 1692
54. J. Heinke, L. Wehofsits, Q. Zhou, C. Zoeller, K.M. Baar, T. Helbing, A. Laib, H. Augustin, C. Bode, C. Patterson, and M. Moser BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis Circ. Res. 103 2008 804 812
55. Y. Yao, M. Jumabay, A. Wang, and K.I. Bostrom Matrix Gla protein deficiency causes arteriovenous malformations in mice J. Clin. Invest. 121 2011 2993 3004
56. F. Itoh, S. Itoh, M.J. Goumans, G. Valdimarsdottir, T. Iso, G.P. Dotto, Y. Hamamori, L. Kedes, M. Kato, and P. ten Dijke Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells EMBO J. 23 2004 541 551
57. I.M. Moya, L. Umans, E. Maas, P.N. Pereira, K. Beets, A. Francis, W. Sents, E.J. Robertson, C.L. Mummery, D. Huylebroeck, and A. Zwijsen Stalk cell phenotype depends on integration of notch and smad1/5 signaling cascades Dev. Cell 22 2012 501 514
58. B. Larrivée, C. Prahst, E. Gordon, R. Del Toro, T. Mathivet, A. Duarte, M. Simons, and A. Eichmann ALK1 signaling inhibits angiogenesis by cooperating with the notch pathway Dev. Cell 22 2012 489 500
59. H. Dorai, S. Vukicevic, and T.K. Sampath Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro J. Cell Physiol. 184 2000 37 45
60. N.W. Morrell, X. Yang, P.D. Upton, K.B. Jourdan, N. Morgan, K.K. Sheares, and R.C. Trembath Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-β(1) and bone morphogenetic proteins Circulation 104 2001 790 795
61. T. Nakaoka, K. Gonda, T. Ogita, Y. Otawara-Hamamoto, F. Okabe, Y. Kira, K. Harii, K. Miyazono, Y. Takuwa, and T. Fujita Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2 J. Clin. Invest. 100 1997 2824 2832
62. H. Dorai, and T.K. Sampath Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture J. Bone Joint Surg. Am. 83-A Suppl. 1 2001 S70 8
63. D.B. Frank, A. Abtahi, D.J. Yamaguchi, S. Manning, Y. Shyr, A. Pozzi, H.S. Baldwin, J.E. Johnson, and M.P. de Caestecker Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension Circ. Res. 97 2005 496 504
64. X. Yang, L. Long, M. Southwood, N. Rudarakanchana, P.D. Upton, T.K. Jeffery, C. Atkinson, H. Chen, R.C. Trembath, and N.W. Morrell Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension Circ. Res. 96 2005 1053 1063
65. J.W. Lowery, and M.P. de Caestecker BMP signaling in vascular development and disease Cytokine Growth Factor Rev. 21 2010 287 298
66. H.W. Farber, and J. Loscalzo Pulmonary arterial hypertension N. Engl. J. Med. 351 2004 1655 1665
67. K.B. Lane, R.D. Machado, M.W. Pauciulo, J.R. Thomson, J.A. Phillips 3rd, J.E. Loyd, W.C. Nichols, and R.C. Trembath Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension Nat. Genet. 26 2000 81 84
68. Z. Deng, J.H. Morse, S.L. Slager, N. Cuervo, K.J. Moore, G. Venetos, S. Kalachikov, E. Cayanis, S.G. Fischer, R.J. Barst, S.E. Hodge, and J.A. Knowles Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene Am. J. Hum. Genet. 67 2000 737 744
69. J. West, J. Harral, K. Lane, Y. Deng, B. Ickes, D. Crona, S. Albu, D. Stewart, and K. Fagan Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions Am. J. Physiol. Lung Cell Mol. Physiol. 295 2008 L744 L755
70. K.H. Hong, Y.J. Lee, E. Lee, S.O. Park, C. Han, H. Beppu, E. Li, M.K. Raizada, K.D. Bloch, and S.P. Oh Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension Circulation 118 2008 722 730
71. Y. Song, L. Coleman, J. Shi, H. Beppu, K. Sato, K. Walsh, J. Loscalzo, and Y.Y. Zhang Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice Am. J. Physiol. Heart Circ. Physiol. 295 2008 H677 H690
72. P.B. Yu, H. Beppu, N. Kawai, E. Li, and K.D. Bloch Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells J. Biol. Chem. 280 2005 24443 24450
73. L. Dewachter, S. Adnot, C. Guignabert, L. Tu, E. Marcos, E. Fadel, M. Humbert, P. Dartevelle, G. Simonneau, R. Naeije, and S. Eddahibi Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension Eur. Respir. J. 34 2009 1100 1110
74. N. Rudarakanchana, J.A. Flanagan, H. Chen, P.D. Upton, R. Machado, D. Patel, R.C. Trembath, and N.W. Morrell Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension Hum. Mol. Genet. 11 2002 1517 1525
75. A. Gangopahyay, M. Oran, E.M. Bauer, J.W. Wertz, S.A. Comhair, S.C. Erzurum, and P.M. Bauer Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation J. Biol. Chem. 286 2011 33134 33140
76. M. Shintani, H. Yagi, T. Nakayama, T. Saji, and R. Matsuoka A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension J. Med. Genet. 46 2009 331 337
77. Z. Huang, D. Wang, K. Ihida-Stansbury, P.L. Jones, and J.F. Martin Defective pulmonary vascular remodeling in Smad8 mutant mice Hum. Mol. Genet. 18 2009 2791 2801
78. K.M. Drake, D. Zygmunt, L. Mavrakis, P. Harbor, L. Wang, S.A. Comhair, S.C. Erzurum, and M.A. Aldred Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8 Am. J. Respir. Crit. Care Med. 184 2011 1400 1408
79. M. Fujiwara, H. Yagi, R. Matsuoka, K. Akimoto, M. Furutani, S. Imamura, R. Uehara, T. Nakayama, A. Takao, M. Nakazawa, and T. Saji Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension Circ. J. 72 2008 127 133
80. R.C. Trembath Mutations in the TGF-β type 1 receptor, ALK1, in combined primary pulmonary hypertension and hereditary haemorrhagic telangiectasia, implies pathway specificity J. Heart Lung Transplant 20 2001 175
81. M. Jerkic, M.G. Kabir, A. Davies, L.X. Yu, B.A. McIntyre, N.W. Husain, M. Enomoto, V. Sotov, M. Husain, M. Henkelman, J. Belik, and M. Letarte Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress Cardiovasc. Res. 92 2011 375 384
82. J. McDonald, P. Bayrak-Toydemir, and R.E. Pyeritz Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis Genet. Med. 13 2011 607 616
83. K.A. McAllister, K.M. Grogg, D.W. Johnson, C.J. Gallione, M.A. Baldwin, C.E. Jackson, E.A. Helmbold, D.S. Markel, W.C. McKinnon, J. Murrel, M.K. McCormick, M.A. Pericak-Vance, P. Heutink, B.A. Oostra, T. Haitjema, C.J.J. Westerman, M.E. Porteous, A.E. Guttmacher, M. Letarte, and D.A. Marchuk Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat. Genet. 8 1994 345 351
84. D.W. Johnson, J.N. Berg, M.A. Baldwin, C.J. Gallione, I. Marondel, S.J. Yoon, T.T. Stenzel, M. Speer, M.A. Pericak-Vance, A. Diamond, A.E. Guttmacher, C.E. Jackson, L. Attisano, R. Kucherlapati, M.E. Porteous, and D.A. Marchuk Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 Nat. Genet. 13 1996 189 195
85. Y. Gu, P. Jin, L. Zhang, X. Zhao, X. Gao, Y. Ning, A. Meng, and Y.G. Chen Functional analysis of mutations in the kinase domain of the TGF-β receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia Blood 107 2006 1951 1954
86. S.A. Abdalla, and M. Letarte Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease J. Med. Genet. 43 2006 97 110
87. N. Ricard, M. Bidart, C. Mallet, G. Lesca, S. Giraud, R. Prudent, J.J. Feige, and S. Bailly Functional analysis of the BMP-9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations Blood 116 2010 1604 1612
88. T. Gridley Notch signaling in vascular development and physiology Development 134 2007 2709 2718
89. M. Morikawa, D. Koinuma, S. Tsutsumi, E. Vasilaki, Y. Kanki, C.H. Heldin, H. Aburatani, and K. Miyazono ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif Nucleic Acids Res. 39 2011 8712 8727
90. M. Benzinou, F.F. Clermont, T.G. Letteboer, J.H. Kim, S. Espejel, K.A. Harradine, J. Arbelaez, M.T. Luu, R. Roy, D. Quigley, M.N. Higgins, M. Zaid, B.E. Aouizerat, J.K. van Amstel, S. Giraud, S. Dupuis-Girod, G. Lesca, H. Plauchu, C.C. Hughes, C.J. Westermann, and R.J. Akhurst Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia Nat. Commun. 3 2012 616
91. Y. Nakagawa, K. Ikeda, Y. Akakabe, M. Koide, M. Uraoka, K.T. Yutaka, R. Kurimoto-Nakano, T. Takahashi, S. Matoba, H. Yamada, M. Okigaki, and H. Matsubara Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo Arterioscler. Thromb. Vasc. Biol. 30 2010 1908 1915
92. A.S. Pachori, L. Custer, D. Hansen, S. Clapp, E. Kemppa, and J. Klingensmith Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway J. Mol. Cell Cardiol. 48 2010 1255 1265
93. Y. Yao, B.J. Bennett, X. Wang, M.E. Rosenfeld, C. Giachelli, A.J. Lusis, and K.I. Bostrom Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification Circ. Res. 107 2010 485 494
94. H. Pannu, V.T. Fadulu, J. Chang, A. Lafont, S.N. Hasham, E. Sparks, P.F. Giampietro, C. Zaleski, A.L. Estrera, H.J. Safi, S. Shete, M.C. Willing, C.S. Raman, and D.M. Milewicz Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections Circulation 112 2005 513 520
95. B.L. Loeys, U. Schwarze, T. Holm, B.L. Callewaert, G.H. Thomas, H. Pannu, J.F. De Backer, G.L. Oswald, S. Symoens, S. Manouvrier, A.E. Roberts, F. Faravelli, M.A. Greco, R.E. Pyeritz, D.M. Milewicz, P.J. Coucke, D.E. Cameron, A.C. Braverman, P.H. Byers, A.M. De Paepe, and H.C. Dietz Aneurysm syndromes caused by mutations in the TGF-β receptor N. Engl. J. Med. 355 2006 788 798
96. J.A. Jones, J.R. Barbour, R.E. Stroud, S. Bouges, S.L. Stephens, F.G. Spinale, and J.S. Ikonomidis Altered transforming growth factor-β signaling in a murine model of thoracic aortic aneurysm J. Vasc. Res. 45 2008 457 468
97. R.C. Johnson, J.A. Leopold, and J. Loscalzo Vascular calcification: pathobiological mechanisms and clinical implications Circ. Res. 99 2006 1044 1059
98. K.A. Hruska, S. Mathew, and G. Saab Bone morphogenetic proteins in vascular calcification Circ. Res. 97 2005 105 114
99. M.Y. Speer, H.Y. Yang, T. Brabb, E. Leaf, A. Look, W.L. Lin, A. Frutkin, D. Dichek, and C.M. Giachelli Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries Circ. Res. 104 2009 733 741
100. M. Kuwana, Y. Okazaki, H. Kodama, K. Izumi, H. Yasuoka, Y. Ogawa, Y. Kawakami, and Y. Ikeda Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation J. Leukoc. Biol. 74 2003 833 845
101. G. Collett, A. Wood, M.Y. Alexander, B.C. Varnum, R.P. Boot-Handford, V. Ohanian, J. Ohanian, Y.W. Fridell, and A.E. Canfield Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes Circ. Res. 92 2003 1123 1129
102. S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa, and Y. Kaneda Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice Biochem. Biophys. Res. Commun. 354 2007 453 458
103. D. Medici, E.M. Shore, V.Y. Lounev, F.S. Kaplan, R. Kalluri, and B.R. Olsen Conversion of vascular endothelial cells into multipotent stem-like cells Nat. Med. 16 2010 1400 1406
104. B.H. Lipton, K.G. Bensch, and M.A. Karasek Histamine-modulated transdifferentiation of dermal microvascular endothelial cells Exp. Cell Res. 199 1992 279 291
105. M. Azhar, R.B. Runyan, C. Gard, L.P. Sanford, M.L. Miller, A. Andringa, S. Pawlowski, S. Rajan, and T. Doetschman Ligand-specific function of transforming growth factor β in epithelial-mesenchymal transition in heart development Dev. Dyn. 238 2009 431 442
106. L.I. Romero, D.N. Zhang, G.S. Herron, and M.A. Karasek Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells J. Cell Physiol. 173 1997 84 92
107. E.M. Shore, and F.S. Kaplan Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP) Bone 43 2008 427 433
108. H.J. Schluesener, and R. Meyermann Immunolocalization of BMP-6, a novel TGF-β-related cytokine, in normal and atherosclerotic smooth muscle cells Atherosclerosis 113 1995 153 156
109. Y. Yao, A.D. Watson, S. Ji, and K.I. Bostrom Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein Circ. Res. 105 2009 575 584
110. K. Bostrom, K.E. Watson, S. Horn, C. Wortham, I.M. Herman, and L.L. Demer Bone morphogenetic protein expression in human atherosclerotic lesions J. Clin. Invest. 91 1993 1800 1809
111. C.R. Dhore, J.P. Cleutjens, E. Lutgens, K.B. Cleutjens, P.P. Geusens, P.J. Kitslaar, J.H. Tordoir, H.M. Spronk, C. Vermeer, and M.J. Daemen Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques Arterioscler. Thromb. Vasc. Biol. 21 2001 1998 2003
112. W. Griethe, R. Schmitt, J.S. Jurgensen, S. Bachmann, K.U. Eckardt, and R. Schindler Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis J. Nephrol. 16 2003 728 732
113. K. Hayashi, S. Nakamura, W. Nishida, and K. Sobue Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription Mol. Cell Biol. 26 2006 9456 9470
114. A. Shioi, M. Katagi, Y. Okuno, K. Mori, S. Jono, H. Koyama, and Y. Nishizawa Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages Circ. Res. 91 2002 9 16
115. Y. Tintut, M. Abedin, J. Cho, A. Choe, J. Lim, and L.L. Demer Regulation of RANKL-induced osteoclastic differentiation by vascular cells J. Mol. Cell Cardiol. 39 2005 389 393
116. S.L. Cheng, J.S. Shao, N. Charlton-Kachigian, A.P. Loewy, and D.A. Towler MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors J. Biol. Chem. 278 2003 45969 45977
117. M. Liberman, R.C. Johnson, D.E. Handy, J. Loscalzo, and J.A. Leopold Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification Biochem. Biophys. Res. Commun. 413 2011 436 441
118. K. Bostrom, D. Tsao, S. Shen, Y. Wang, and L.L. Demer Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells J. Biol. Chem. 276 2001 14044 14052
119. K.A. Lomashvili, X. Wang, R. Wallin, and W.C. O'Neill Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification J. Biol. Chem. 286 2011 28715 28722
120. R.F. Ankeny, V.H. Thourani, D. Weiss, J.D. Vega, W.R. Taylor, R.M. Nerem, and H. Jo Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves-association with low BMP antagonists and SMAD6 PLoS One 6 2011 e20969
121. H.L. Tan, E. Glen, A. Töpf, D. Hall, J.J. O'Sullivan, L. Sneddon, C. Wren, P. Avery, R.J. Lewis, P. Ten Dijke, H.M. Arthur, J.A. Goodship, and B.D. Keavney Non-synonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation Hum. Mutat. 33 2012 720 727
122. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 1971 1182 1186
123. D.F. Hayes Bevacizumab treatment for solid tumors: boon or bust? J.A.M.A. 305 2011 506 508
124. K.J. Gotink, and H.M. Verheul Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Angiogenesis 13 2010 1 14
125. S. Hatakeyama, Y. Ohara-Nemoto, S. Kyakumoto, and M. Satoh Expression of bone morphogenetic protein in human adenocarcinoma cell line Biochem. Biophys. Res. Commun. 190 1993 695 701
126. S. Hatakeyama, Y.H. Gao, Y. Ohara-Nemoto, H. Kataoka, and M. Satoh Expression of bone morphogenetic proteins of human neoplastic epithelial cells Biochem. Mol. Biol. Int. 42 1997 497 505
127. H. Ide, T. Yoshida, N. Matsumoto, K. Aoki, Y. Osada, T. Sugimura, and M. Terada Growth regulation of human prostate cancer cells by bone morphogenetic protein-2 Cancer Res. 57 1997 5022 5027
128. Y. Kiyozuka, H. Nakagawa, H. Senzaki, Y. Uemura, S. Adachi, Y. Teramoto, T. Matsuyama, K. Bessho, and A. Tsubura Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer Anticancer Res. 21 2001 1723 1730
129. J. Kleeff, H. Maruyama, T. Ishiwata, H. Sawhney, H. Friess, M.W. Buchler, and M. Korc Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo Gastroenterology 116 1999 1202 1216
130. H. Deng, R. Makizumi, T.S. Ravikumar, H. Dong, W. Yang, and W.L. Yang Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells Exp. Cell Res. 313 2007 1033 1044
131. M. Bieniasz, K. Oszajca, M. Eusebio, J. Kordiak, J. Bartkowiak, and J. Szemraj The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients Lung cancer 66 2009 319 326
132. O. Kozawa, H. Matsuno, and T. Uematsu Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts J. Cell Biochem. 81 2001 430 436
133. E.M. Langenfeld, S.E. Calvano, F. Abou-Nukta, S.F. Lowry, P. Amenta, and J. Langenfeld The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells Carcinogenesis 24 2003 1445 1454
134. E.M. Langenfeld, and J. Langenfeld Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors Mol. Cancer Res. 2 2004 141 149
135. T. Rothhammer, F. Bataille, T. Spruss, G. Eissner, and A.K. Bosserhoff Functional implication of BMP-4 expression on angiogenesis in malignant melanoma Oncogene 26 2007 4158 4170
136. D.D. Hu-Lowe, E. Chen, L. Zhang, K.D. Watson, P. Mancuso, P. Lappin, G. Wickman, J.H. Chen, J. Wang, X. Jiang, K. Amundson, R. Simon, A. Erbersdobler, S. Bergqvist, Z. Feng, T.A. Swanson, B.H. Simmons, J. Lippincott, G.F. Casperson, W.J. Levin, C.G. Stampino, D.R. Shalinsky, K.W. Ferrara, W. Fiedler, and F. Bertolini Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies Cancer Res. 71 2011 1362 1373
137. S.I. Cunha, E. Pardali, M. Thorikay, C. Anderberg, L. Hawinkels, M.J. Goumans, J. Seehra, C.H. Heldin, P. ten Dijke, and K. Pietras Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis J. Exp. Med. 207 2010 85 100
138. T. Seki, J. Yun, and S.P. Oh Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling Circ. Res. 93 2003 682 689
139. D. Mitchell, E.G. Pobre, A.W. Mulivor, A.V. Grinberg, R. Castonguay, T.E. Monnell, N. Solban, J.A. Ucran, R.S. Pearsall, K.W. Underwood, J. Seehra, and R. Kumar ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth Mol. Cancer Ther. 9 2010 379 388
140. A. Duwel, N. Eleno, M. Jerkic, M. Arevalo, J.P. Bolanos, C. Bernabeu, and J.M. Lopez-Novoa Reduced tumor growth and angiogenesis in endoglin- haploinsufficient mice Tumour Biol. 28 2007 1 8
141. L.J. Hawinkels, P. Kuiper, E. Wiercinska, H.W. Verspaget, Z. Liu, E. Pardali, C.F. Sier, and P. ten Dijke Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis Cancer Res. 70 2010 4141 4150
142. R. Castonguay, E.D. Werner, R.G. Matthews, E. Presman, A.W. Mulivor, N. Solban, D. Sako, R.S. Pearsall, K.W. Underwood, J. Seehra, R. Kumar, and A.V. Grinberg Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth J. Biol. Chem. 286 2011 30034 30046
143. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
144. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, R. Stewart, I.I. Slukvin, and J.A. Thomson Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
145. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
146. N. Sun, N.J. Panetta, D.M. Gupta, K.D. Wilson, A. Lee, F. Jia, S. Hu, A.M. Cherry, R.C. Robbins, M.T. Longaker, and J.C. Wu Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells Proc. Natl. Acad. Sci. U S A 106 2009 15720 15725
147. T. Aasen, A. Raya, M.J. Barrero, E. Garreta, A. Consiglio, F. Gonzalez, R. Vassena, J. Bilić, V. Pekarik, G. Tiscornia, M. Edel, S. Boué, Izpisúa, and J.C. Belmonte Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes Nat. Biotechnol. 26 2008 1276 1284
148. J. Hanna, S. Markoulaki, P. Schorderet, B.W. Carey, C. Beard, M. Wernig, M.P. Creyghton, E.J. Steine, J.P. Cassady, R. Foreman, C.J. Lengner, J.A. Dausman, and R. Jaenisch Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency Cell 133 2008 250 264
149. K. Saha, and R. Jaenisch Technical challenges in using human induced pluripotent stem cells to model disease Cell Stem Cell 5 2009 584 595
150. J. Zhang, Q. Lian, G. Zhu, F. Zhou, L. Sui, C. Tan, R.A. Mutalif, R. Navasankari, Y. Zhang, H.F. Tse, C.L. Stewart, and A. Colman A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects Cell Stem Cell 8 2011 31 45
151. L. Ikonomou, A.R. Hemnes, G. Bilousova, R. Hamid, J.E. Loyd, A.K. Hatzopoulos, D.N. Kotton, S.M. Majka, and E.D. Austin Programmatic change: lung disease research in the era of induced pluripotency Am. J. Physiol. Lung Cell Mol. Physiol. 301 2011 L830 L835
152. P.B. Yu, C.C. Hong, C. Sachidanandan, J.L. Babitt, D.Y. Deng, S.A. Hoyng, H.Y. Lin, K.D. Bloch, and R.T. Peterson Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism Nat. Chem. Biol. 4 2008 33 41
153. G.D. Cuny, P.B. Yu, J.K. Laha, X. Xing, J.F. Liu, C.S. Lai, D.Y. Deng, C. Sachidanandan, K.D. Bloch, and R.T. Peterson Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors Bioorg. Med. Chem. Lett. 18 2008 4388 4392
154. C.C. Hong, and P.B. Yu Applications of small molecule BMP inhibitors in physiology and disease Cytokine Growth Factor Rev. 20 2009 409 418
155. H. Zhang, and A. Bradley Mice deficient for BMP-2 are nonviable and have defects in amnion/chorion and cardiac development Development 122 1996 2977 2986
156. L. Anderson, J.W. Lowery, D.B. Frank, T. Novitskaya, M. Jones, D.P. Mortlock, R.L. Chandler, and M.P. de Caestecker BMP-2 and BMP-4 exert opposing effects in hypoxic pulmonary hypertension Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 2010 R833 R842
157. H. Beppu, F. Ichinose, N. Kawai, R.C. Jones, P.B. Yu, W.M. Zapol, K. Miyazono, E. Li, and K.D. Bloch BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia Am. J. Physiol. Lung Cell Mol. Physiol. 287 2004 L1241 L1247
158. Y. Song, J.E. Jones, H. Beppu, J.F. Keaney Jr., J. Loscalzo, and Y.Y. Zhang Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice Circulation 112 2005 553 562
159. S.P. Oh, T. Seki, K.A. Goss, T. Imamura, Y. Yi, P.K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, and E. Li Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis Proc. Natl. Acad. Sci. U S A 97 2000 2626 2631
160. L.D. Urness, L.K. Sorensen, and D.Y. Li Arteriovenous malformations in mice lacking activin receptor-like kinase-1 Nat. Genet. 26 2000 328 331
161. S. Srinivasan, M.A. Hanes, T. Dickens, M.E. Porteous, S.P. Oh, L.P. Hale, and D.A. Marchuk A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2 Hum. Mol. Genet. 12 2003 473 482
162. S.O. Park, Y.J. Lee, T. Seki, K.H. Hong, N. Fliess, Z. Jiang, A. Park, X. Wu, V. Kaartinen, B.L. Roman, and S.P. Oh ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 Blood 111 2008 633 642
163. N. El-Bizri, L. Wang, S.L. Merklinger, C. Guignabert, T. Desai, T. Urashima, A.Y. Sheikh, R.H. Knutsen, R.P. Mecham, Y. Mishina, and M. Rabinovitch Smooth muscle protein 22alpha-mediated patchy deletion of BMPR1a impairs cardiac contractility but protects against pulmonary vascular remodeling Circ. Res. 102 2008 380 388
164. N. El-Bizri, C. Guignabert, L. Wang, A. Cheng, K. Stankunas, C.P. Chang, Y. Mishina, and M. Rabinovitch SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis Development 135 2008 2981 2991
165. C. Park, K. Lavine, Y. Mishina, C.X. Deng, D.M. Ornitz, and K. Choi Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation Development 133 2006 3473 3484
166. H.M. Arthur, J. Ure, A.J. Smith, G. Renforth, D.I. Wilson, E. Torsney, R. Charlton, D.V. Parums, T. Jowett, D.A. Marchuk, J. Burn, and A.G. Diamond Endoglin, an ancillary TGF-β receptor, is required for extraembryonic angiogenesis and plays a key role in heart development Dev. Biol. 217 2000 42 53
167. M. Mahmoud, K.R. Allinson, Z. Zhai, R. Oakenfull, P. Ghandi, R.H. Adams, M. Fruttiger, and H.M. Arthur Pathogenesis of arteriovenous malformations in the absence of endoglin Circ. Res. 106 2010 1425 1433
168. R.J. Lechleider, J.L. Ryan, L. Garrett, C. Eng, C. Deng, A. Wynshaw-Boris, and A.B. Roberts Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion Dev. Biol. 240 2001 157 167
169. C. Gallione, A.S. Aylsworth, J. Beis, T. Berk, B. Bernhardt, R.D. Clark, C. Clericuzio, C. Danesino, J. Drautz, J. Fahl, Z. Fan, M.E. Faughnan, A. Ganguly, J. Garvie, K. Henderson, U. Kini, T. Leedom, M. Ludman, A. Lux, M. Maisenbacher, S. Mazzucco, C. Olivieri, J.K. Ploos van Amstel, N. Prigoda-Lee, R.E. Pyeritz, W. Reardon, K. Vandezande, J.D. Waldman, R.I. White Jr., C.A. Williams, and D.A. Marchuk Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome Am. J. Med. Genet. A. 152A 2010 333 339
170. C.J. Gallione, J.A. Richards, T.G. Letteboer, D. Rushlow, N.L. Prigoda, T.P. Leedom, A. Ganguly, A. Castells, J.K. Ploos van Amstel, C.J. Westermann, R.E. Pyeritz, and D.A. Marchuk SMAD4 mutations found in unselected HHT patients J. Med. Genet. 43 2006 793 797
171. Y. Lan, B. Liu, H. Yao, F. Li, T. Weng, G. Yang, W. Li, X. Cheng, N. Mao, and X. Yang Essential role of endothelial Smad4 in vascular remodeling and integrity Mol. Cell Biol. 27 2007 7683 7692
172. X. Yang, L.H. Castilla, X. Xu, C. Li, J. Gotay, M. Weinstein, P.P. Liu, and C.X. Deng Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5 Development 126 1999 1571 1580
173. H. Chang, D. Huylebroeck, K. Verschueren, Q. Guo, M.M. Matzuk, and A. Zwijsen Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects Development 126 1999 1631 1642
174. K.M. Galvin, M.J. Donovan, C.A. Lynch, R.I. Meyer, R.J. Paul, J.N. Lorenz, V. Fairchild-Huntress, K.L. Dixon, J.H. Dunmore, M.A. Gimbrone Jr., D. Falb, and D. Huszar A role for smad6 in development and homeostasis of the cardiovascular system Nat. Genet. 24 2000 171 174
175. Q. Chen, H. Chen, D. Zheng, C. Kuang, H. Fang, B. Zou, W. Zhu, G. Bu, T. Jin, Z. Wang, X. Zhang, J. Chen, L.J. Field, M. Rubart, W. Shou, and Y. Chen Smad7 is required for the development and function of the heart J. Biol. Chem. 284 2009 292 300